Literature DB >> 23478496

A critical role for immature muscle precursors in myositis.

Anne Tournadre1, Pierre Miossec.   

Abstract

The innate and adaptive immune responses contribute to the development of inflammatory myopathies; the innate immune system does so through activation of the type I interferon and Toll-like receptor pathways. Dendritic cells have a pivotal role in the development of both adaptive and innate immune responses. Equipped with a range of pattern-recognition receptors, dendritic cells link innate and adaptive immunity. This Perspectives article discusses novel concepts in myositis, focusing on immature muscle precursors. Of interest, the immature muscle precursors involved in regeneration are associated with upregulation of HLA class I antigens and myositis-associated autoantigens, as well as activation of the Toll-like receptor pathway and production of type I interferon, and could have a critical contribution to the pathogenesis of myositis. These regenerating immature muscle cells might also be a target of the immune response in myositis, thereby explaining why muscle regeneration is not effective in the context of such inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23478496     DOI: 10.1038/nrrheum.2013.26

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  40 in total

1.  Myeloid dendritic cells in inclusion-body myositis and polymyositis.

Authors:  Steven A Greenberg; Geraldine S Pinkus; Anthony A Amato; Jack L Pinkus
Journal:  Muscle Nerve       Date:  2007-01       Impact factor: 3.217

2.  Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis.

Authors:  Consuelo M López de Padilla; Abbe N Vallejo; Kelly T McNallan; Richard Vehe; Stephen A Smith; Allan B Dietz; Stanimir Vuk-Pavlovic; Ann M Reed
Journal:  Arthritis Rheum       Date:  2007-05

3.  Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies.

Authors:  A M Emslie-Smith; K Arahata; A G Engel
Journal:  Hum Pathol       Date:  1989-03       Impact factor: 3.466

4.  Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis.

Authors:  G Chevrel; G Page; C Granet; N Streichenberger; A Varennes; P Miossec
Journal:  J Neuroimmunol       Date:  2003-04       Impact factor: 3.478

5.  Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines.

Authors:  A Tournadre; V Lenief; P Miossec
Journal:  Arthritis Rheum       Date:  2010-07

6.  Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy.

Authors:  Kerry B Stone; Chester V Oddis; Noreen Fertig; Yasuhiro Katsumata; Mary Lucas; Molly Vogt; Robyn Domsic; Dana P Ascherman
Journal:  Arthritis Rheum       Date:  2007-09

7.  Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls.

Authors:  I Lundberg; J M Brengman; A G Engel
Journal:  J Neuroimmunol       Date:  1995-12       Impact factor: 3.478

8.  Stimulation of myoblast proliferation in culture by leukaemia inhibitory factor and other cytokines.

Authors:  L Austin; A W Burgess
Journal:  J Neurol Sci       Date:  1991-02       Impact factor: 3.181

9.  RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

Authors:  Christina M Lau; Courtney Broughton; Abigail S Tabor; Shizuo Akira; Richard A Flavell; Mark J Mamula; Sean R Christensen; Mark J Shlomchik; Gregory A Viglianti; Ian R Rifkin; Ann Marshak-Rothstein
Journal:  J Exp Med       Date:  2005-10-31       Impact factor: 14.307

10.  T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells.

Authors:  A Bender; N Ernst; A Iglesias; K Dornmair; H Wekerle; R Hohlfeld
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more
  9 in total

1.  Dermatomyositis: immunological landscape, biomarkers, and potential candidate drugs.

Authors:  Ruxue Yin; Gangjian Wang; Lei Zhang; Tianfang Li; Shengyun Liu
Journal:  Clin Rheumatol       Date:  2021-01-03       Impact factor: 2.980

2.  A tissue communication network coordinating innate immune response during muscle stress.

Authors:  Nicole Green; Justin Walker; Alexandria Bontrager; Molly Zych; Erika R Geisbrecht
Journal:  J Cell Sci       Date:  2018-12-18       Impact factor: 5.285

Review 3.  Cell death, clearance and immunity in the skeletal muscle.

Authors:  C Sciorati; E Rigamonti; A A Manfredi; P Rovere-Querini
Journal:  Cell Death Differ       Date:  2016-02-12       Impact factor: 15.828

Review 4.  Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.

Authors:  E M Moran; F L Mastaglia
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

5.  Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies.

Authors:  Nickie Seto; Jose Jiram Torres-Ruiz; Carmelo Carmona-Rivera; Iago Pinal-Fernandez; Katherine Pak; Monica M Purmalek; Yuji Hosono; Catia Fernandes-Cerqueira; Prateek Gowda; Nathan Arnett; Alexander Gorbach; Olivier Benveniste; Diana Gómez-Martín; Albert Selva-O'Callaghan; José C Milisenda; Josep M Grau-Junyent; Lisa Christopher-Stine; Frederick W Miller; Ingrid E Lundberg; J Michelle Kahlenberg; Adam I Schiffenbauer; Andrew Mammen; Lisa G Rider; Mariana J Kaplan
Journal:  JCI Insight       Date:  2020-02-13

Review 6.  Inflammatory predisposition predicts disease phenotypes in muscular dystrophy.

Authors:  Yuko Nitahara-Kasahara; Shin'ichi Takeda; Takashi Okada
Journal:  Inflamm Regen       Date:  2016-09-05

Review 7.  A Path to Prediction of Outcomes in Juvenile Idiopathic Inflammatory Myopathy.

Authors:  Ann Marie Reed; Cynthia S Crowson; Jeffrey Arthur Dvergsten
Journal:  Front Immunol       Date:  2019-04-02       Impact factor: 7.561

8.  Aberrant Expression of High Mobility Group Box Protein 1 in the Idiopathic Inflammatory Myopathies.

Authors:  Jessica Day; Sophia Otto; Kathy Cash; Preethi Eldi; Pravin Hissaria; Susanna Proudman; Vidya Limaye; John D Hayball
Journal:  Front Cell Dev Biol       Date:  2020-04-17

9.  Ten genes are considered as potential biomarkers for the diagnosis of dermatomyositis.

Authors:  Lu Xiao; Wei Xiao; Shudian Lin
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.